Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1977 Feb;30(2):160–164. doi: 10.1136/jcp.30.2.160

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.

K Bridges, E J Lowbury
PMCID: PMC476342  PMID: 321478

Abstract

Topical chemoprophylaxis of extensive burns with silver sulphadiazine cream led to a large increase in the proportion of sulphadiazine-resistant Gram-negative bacilli in a burns unit. When all sulphonamide treatment in the ward was stopped; the incidence of sulphonamide-resistant strains fell back to levels similar to those recorded when silver sulphadiazine treatment was introduced. This was associated with a large reduction in the incidence of resistance of certain Gram-negative bacilli (especially Klebstella sp) to several antibiotics. Transferable resistance to sulphadiazine, shown by conjugation experiments with Escherichia coli K12, was found in a majority of the strains of Klebsiella sp tested, and in other species. A pattern of transferable resistance to tetracycline, cephaloridine, chloramphenicol, ampicillin, carbenicillin, and sulphadiazine (T Ce Cl A Ca S) was found in four of the 22 strains of Klebsiella tested, and closely related patterns were transferred by five other strains. These patterns of resistance were commonly found in Klebsiella sp isolated from burns in the period before the withdrawal of sulphonamides from the ward but were found in none of the Klebsiella strains isolated in the first six months after that period. Strains of Acinetobacter and Proteus, in which transferable resistance was not found, showed no appreciable fall or rise in sulphadiazine resistance; there was no fall in resistance of these organisms to tetracycline, cephaloridine, chloramphenicol, ampicillin or carbenicillin on withdrawal of sulphonamides from the ward, but there were substantial falls in resistance of Acinetobacter to kanamycin, gentamicin, trimethoprim, and tetracycline which were probably not caused by the withdrawal of sulphonamides.

Full text

PDF
160

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CASON J. S., LOWBURY E. J. Prophylactic chemotherapy for burns. Studies on the local and systemic use of combined therapy. Lancet. 1960 Sep 3;2(7149):501–507. doi: 10.1016/s0140-6736(60)91539-7. [DOI] [PubMed] [Google Scholar]
  2. Cason J. S., Jackson D. M., Lowbury E. J., Ricketts C. R. Antiseptic and aseptic prophylaxis for burns: use of silver nitrate and of isolators. Br Med J. 1966 Nov 26;2(5525):1288–1294. doi: 10.1136/bmj.2.5525.1288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fox C. L., Jr, Rappole B. W., Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969 May;128(5):1021–1026. [PubMed] [Google Scholar]
  4. Hummel R. P., MacMillan B. G., Altemeier W. A. Topical and systemic antibacterial agents in the treatment of burns. Ann Surg. 1970 Sep;172(3):370–384. doi: 10.1097/00000658-197009000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lowbury E. J., Babb J. R., Bridges K., Jackson D. M. Topical chemoprophylaxis with silver sulphadiazine and silver nitrate chlorhexidine creams: emergence of sulphonamide-resistant Gram-negative bacilli. Br Med J. 1976 Feb 28;1(6008):493–496. doi: 10.1136/bmj.1.6008.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lowbury E. J., Babb J. R., Roe E. Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa. Lancet. 1972 Nov 4;2(7784):941–945. doi: 10.1016/s0140-6736(72)92469-5. [DOI] [PubMed] [Google Scholar]
  7. Lowbury E. J., Jackson D. M., Ricketts C. R., Davis B. Topical chemoprophylaxis for burns: trials of creams containing silver sulphadiazine and trimethoprim. Injury. 1971 Jul;3(1):18–24. doi: 10.1016/s0020-1383(71)80131-6. [DOI] [PubMed] [Google Scholar]
  8. Lowbury E. J., Lilly H. A., Cason J. S., Jackson D. M., Bull J. P., Davies J. W., Ford P. M. Alternative forms of local treatment for burns. Lancet. 1971 Nov 20;2(7734):1105–1111. doi: 10.1016/s0140-6736(71)91269-4. [DOI] [PubMed] [Google Scholar]
  9. Price D. J., Sleigh J. D. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet. 1970 Dec 12;2(7685):1213–1215. doi: 10.1016/s0140-6736(70)92179-3. [DOI] [PubMed] [Google Scholar]
  10. Roe E., Lowbury E. J. Changes in antibiotic sensitivity patterns of Gram-negative bacilli in burns. J Clin Pathol. 1972 Feb;25(2):176–178. doi: 10.1136/jcp.25.2.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Stanford W., Rappole B. W., Fox C. L., Jr Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma. 1969 May;9(5):377–388. doi: 10.1097/00005373-196905000-00002. [DOI] [PubMed] [Google Scholar]
  12. TOPLEY E., LOWBURY E. J. L., HURST L. Bacteriological control of aureomycin therapy. Lancet. 1951 Jan 13;1(6646):87–89. doi: 10.1016/s0140-6736(51)91169-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES